Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study

Abstract

Aims

While patients with diabetes mellitus (DM) have more extensive coronary disease and worse survival after acute myocardial infarction (AMI) than patients without DM, data on whether they experience more angina are conflicting.

Methods

We examined angina prevalence over the year following AMI among 3367 patients, including 1080 (32%) with DM, from 24 US hospitals enrolled in the TRIUMPH registry from 2005 to 2008.

Results

Patients with vs. without DM were more likely to be treated with antianginal medications both at discharge and over follow up. Despite more aggressive angina therapy, patients with vs. without DM had higher prevalence and severity of angina prior to AMI (49 vs. 43%, p = 0.001) and at each follow-up assessment, although rates of angina declined in both groups over time. In a hierarchical, multivariable, repeated-measures model that adjusted for multiple demographic and clinical factors including severity of coronary disease and in-hospital revascularization, DM was associated with a greater odds of angina over the 12 months of follow up; this association increased in magnitude over time (12-month OR 1.18, 95% CI 1.01–1.37; DM*time p_interaction = 0.008).

Conclusions

Contrary to conventional wisdom, angina is more prevalent and more severe among patients with DM, both prior to and following AMI. This effect is amplified over time and independent of patient and treatment factors, including the presence of multivessel disease and coronary revascularization. This increased burden of angina may be due to more diffuse nature of coronary disease, more rapid progression of coronary disease over time, or greater myocardial demand among DM patients.

Keywords

Angina diabetes mellitus myocardial infarction

Get full access to this article

View all access options for this article.

References

Stolker

Sun

Conaway

. Importance of measuring glycosylated hemoglobin in patients with myocardial infarction and known diabetes mellitus. Am J Cardiol 2010; 105: 1090–1094.

Abi Khalil

Roussel

Mohammedi

. Cause-specific mortality in diabetes: recent changes in trend mortality. Eur J Prev Cardiol 2012; 19: 374–381.

Donahoe

Stewart

McCabe

. Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298: 765–775.

Duarte

Castela

Reis

. Acute coronary syndrome in a diabetic population–risk factors and clinical and angiographic characteristics. Rev Port Cardiol 2003; 22: 1077–1088.

Herlitz

Wognsen

Emanuelsson

. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 1996; 19: 698–703.

Haffner

Lehto

Ronnemaa

. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–234.

Marchant

Umachandran

Stevenson

. Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993; 22: 1433–1437.

Murray

O’Brien

Mulrooney

. Autonomic dysfunction and silent myocardial ischaemia on exercise testing in diabetes mellitus. Diabet Med 1990; 7: 580–584.

Chiariello

Indolfi

Cotecchia

. Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J 1985; 110: 529–534.

10.

May

Arildsen

Damsgaard

. Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study. Cardiovasc Res 1997; 34: 241–247.

11.

Caracciolo

Chaitman

Forman

. Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot Investigators. Circulation 1996; 93: 2097–2105.

12.

Peterson

Spertus

Magid

. The impact of diabetes on one-year health status outcomes following acute coronary syndromes. BMC Cardiovasc Disord 2006; 6: 41–41.

13.

Morrow

Scirica

Chaitman

. Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial. Circulation 2009; 119: 2032–2039.

14.

Maddox

Reid

Spertus

. Angina at 1 year after myocardial infarction: prevalence and associated findings. Arch Intern Med 2008; 168: 1310–1316.

15.

Arnold

Morrow

Lei

. Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial. Circ Cardiovasc Qual Outcomes 2009; 2: 344–353.

16.

Arnold

Chan

Jones

. Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients’ Health Status (TRIUMPH): design and rationale of a prospective multicenter registry. Circ Cardiovasc Qual Outcomes 2011; 4: 467–476.

17.

Spertus

Winder

Dewhurst

. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995; 25: 333–341.

18.

Ware

Jr Kosinski

Keller

. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–233.

19.

Spertus

Salisbury

Jones

. Predictors of quality-of-life benefit after percutaneous coronary intervention. Circulation 2004; 110: 3789–3794.

20.

Muller-Nordhorn

Roll

Willich

. Comparison of the short form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease. Heart 2004; 90: 523–527.

21.

Cohen

. Statistical power analysis for the behavioral sciences, 2nd ed. New Jersey: Lawrence Erlbaum, 1988.

22.

Kroenke

Spitzer

Williams

. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–613.

23.

Eagle

Lim

Dabbous

. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727–2733.

24.

Fleiss

Levin

Paik

. Statistical methods for rates and proportions, 3rd ed. Hoboken, NJ: Wiley, 2003.

25.

Woodfield

Lundergan

Reiner

. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1996; 28: 1661–1669.

26.

Yeh

Normand

Wolf

. Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention. Circulation 2011; 124: 1557–1564.

27.

Marciano

Galderisi

Gargiulo

. Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease. Eur J Nucl Med Mol Imaging 2012; 39: 1199–11206.

28.

Schalkwijk

Stehouwer

. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005; 109: 143–159.

29.

Stanley

Lopaschuk

McCormack

. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 1997; 34: 25–33.

30.

Abdallah

Wang

Magnuson

. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. JAMA 2013; 310: 1581–1590.

31.

Jansen

Niemeyer

Cleophas

. Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis. Angiology 2000; 51: 1007–1012.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.07 MB